MSB 1.86% $1.32 mesoblast limited

Ann: Half Year Report and Accounts (including Appendix 4D), page-229

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,016 Posts.
    lightbulb Created with Sketch. 2135
    Unlike the other three expedited programs, the accelerated approval is a pathway. ... The difference is that drugs granted accelerated approval must promptly conduct post-marketing confirmatory trials to verify the clinical benefit (as early as underway at the time the marketing application is submitted


    Boy Dr Mcscientist, you are certainly broadening the focus.

    Maybe Msb will notify the market of funding for confirmatory trials which would be required for accelerated approval??

    Oh, that’s right, they just did that. I don’t like to answer nonholders but sometimes I just can’t help myself.

    You lot are like being at a football match and barracking against the vocal supporters. No club colours worn , no acknowledgment of great plays. When pressed on which club you support, you answer , oh me, I’m a tennis player, No idea about football.

    That was a non hangover analogy- I will endeavour to improve.

    Reg


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.32
Change
-0.025(1.86%)
Mkt cap ! $1.507B
Open High Low Value Volume
$1.35 $1.35 $1.31 $2.699M 2.040M

Buyers (Bids)

No. Vol. Price($)
2 34995 $1.32
 

Sellers (Offers)

Price($) Vol. No.
$1.33 10374 2
View Market Depth
Last trade - 16.10pm 31/10/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.